Advisory Board

Home / Advisory Board

Olga Krylova

  • Director of Business Development, Otsuka Europe.
  • Worked as a scientist at the leading research centers in the UK (UCL, Imperial College) and in the industry (at Glaxosmithkline), later joining Mitsui&Co as a senior BD&L analyst.
  • In 2011 joined Pfizer as Senior Director, Emerging Science & Innovation, where she was responsible for scientific cooperation in Russia, Eastern Europe and Israel. Since 2016, was responsible for Pfizer’s scientific research and development partnerships in the UK.

 

Vitaly Proutski

  • Former head of R&D in Russia and Eastern Europe and head of R&D bioinformatics support, AstraZeneca
  • 15+ years of experience in Bio-IT (EU, Great Britain)

Alexey Lugovskoy

  • Entrepreneur In Residence at Atlas Venture

  • Held key positions at Dragonfly Therapeutics, Morphic Therapeutic, Biogen Idec and Merrimack Pharmaceuticals in R&D and drug development

Dmitry Samarsky

  • CTO at Sirnaomics, ex-CSO at Silence Therapeutics
  • distinguished editor at Journal of RNAi & Gene Silencing
  • 20+ years of experience (R&D, business development, sales) in the USA and developing countries

Yan Lavrovsky

  • CEO and CSO, R-Pharm Overseas, Inc (USA)
  • Held senior positions in Avineuro Pharmaceuticals, Inc., ChemDiv, Inc. and Serono, Geneva, Switzerland and Boston, Massachusetts

Mikhail Samsonov

  • Medical director, R-Pharm
  • More than 17 years of experience in BMS and Novartis on various senior and executive positions in clinical development and medical questions